KD gentamicin 10MG/ML, KD7.5% sodium bicarbonate, and rpmi 1640 with L-glutamine+25MMHEPES+50UG./ML.hypoxanthine

Ended Purchase Order Awarded

Contract number
75N93021P01493
Awardee
Awarding agency
Obligated
$14,563

Award facts

Contract value 100% obligated
$14,563.35 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6810 Chemicals
Set-aside
No set-aside
Competition
Competed under SAP · 3 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Columbia, MD 21045, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases, a component of the U.S. Department of Health and Human Services, to K-D Medical, Inc., doing business as KD Medical. The $14,563.35 firm-fixed-price purchase order is for the supply of gentamicin, sodium bicarbonate, and cell culture media. K-D Medical is a primary molecular biology manufacturer and supplier to federal health agencies, including the NIH, CDC, and FDA, as well as major academic institutions and pharmaceutical companies. This award is not associated with a larger contract vehicle and has no set-aside designation.

Quick answers

Who was awarded contract 75N93021P01493?

75N93021P01493 was awarded to K-D Medical, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 22, 2021.

How much is contract 75N93021P01493 worth?

The government has obligated $14,563 on 75N93021P01493.

Was contract 75N93021P01493 competed?

The extent of competition for 75N93021P01493 was competed under sap. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award